首页> 外文期刊>ACS medicinal chemistry letters >Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation
【24h】

Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation

机译:发现以DFG-out构型结合的LIM激酶2的III型抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

The first allosteric, type III inhibitor of LIM-kinase 2 (LIMK2) is reported. A series of molecules that feature both an N-phenylsulfonamide and tertiary amide were not only very potent at LIMK2 but also were extremely selective against a panel of other kinases. Enzymatic kinetic studies showed these molecules to be noncompetitive with ATP, suggesting allosteric inhibition. X-ray crystallography confirmed that these sulfonamides are a rare example of a type III kinase inhibitor that binds away from the highly conserved hinge region and instead resides in the hydrophobic pocket formed in the DFG-out conformation of the kinase, thus accounting for the high level of selectivity observed.
机译:据报道,第一种变构,III型LIM激酶2抑制剂(LIMK2)。一系列同时具有N-苯基磺酰胺和叔酰胺特征的分子不仅对LIMK2十分有效,而且对一组其他激酶具有极高的选择性。酶动力学研究表明这些分子与ATP不竞争,暗示了变构抑制作用。 X射线晶体学证实,这些磺酰胺类是III型激酶抑制剂的稀有实例,其与高度保守的铰链区结合而位于激酶的DFG-out构象中形成的疏水袋中,因此占较高的比例。观察到的选择性水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号